Correction: Khongrum et al. Safety and Effects of Lactobacillus paracasei TISTR 2593 Supplementation on Improving Cholesterol Metabolism and Atherosclerosis-Related Parameters in Subjects with Hypercholesterolemia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Nutrients 2023, 15, 661

Jurairat Khongrum; Pratoomporn Yingthongchai; Kongsak Boonyapranai; Wachira Wongtanasarasin; Paitoon Aobchey; Suriya Tateing; Aree Prachansuwan; Jaruwan Sitdhipol; Kanidta Niwasabutra; Punnathorn Thaveethaptaikul; Pongsathon Phapugrangkul; Pennapa Chonpathompikunlert

doi:10.3390/nu16152521

,

and

¹

Science and Technology Research Institute, Chiang Mai University, Chiang Mai 50200, Thailand

²

Functional Food Research Center for Well-Being, Science and Technology Research Institute, Chiang Mai University, Chiang Mai 50200, Thailand

³

Research Institute for Health Science, Chiang Mai University, Chiang Mai 50200, Thailand

⁴

Department of Emergency Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand

Nutrients2024, 16(15), 2521;https://doi.org/10.3390/nu16152521

This article belongs to the Special Issue Prebiotics, Probiotics and Nutrients in Cardiovascular and Kidney Disease

Version Notes

Order Reprints

Error in Table

In the original publication [1], there was a mistake in Table 2 as published. In the table, we quoted the baseline of blood parameter-ALT of the L. paracasei TISTR 2593 group which was at “25.85 ± 418.66 U/L”.

The corrected blood parameter appears below.

ALT on the baseline of the L. paracasei TISTR 2593 group was “25.85 ± 18.66 U/L”.

Text Correction

There was an error in the original publication in Materials and Methods and Discussion [1]. We stated that the dose of “L. paracasei TISTR 2593” was at “1.05 × 10¹⁰ CFU/g”.

A correction has been made to Materials and Methods, Section 2.2., paragraph 2.

The correct dose of L. paracasei TISTR 2593 is “1.05 × 10⁹ CFU/g”.

A correction has been made to Discussion, paragraphs 1 and 2.

The correct dose of L. paracasei TISTR 2593 is “1.05 × 10⁹ CFU/g”.

Reference

Khongrum, J.; Yingthongchai, P.; Boonyapranai, K.; Wongtanasarasin, W.; Aobchey, P.; Tateing, S.; Prachansuwan, A.; Sitdhipol, J.; Niwasabutra, K.; Thaveethaptaikul, P.; et al. Safety and Effects of Lactobacillus paracasei TISTR 2593 Supplementation on Improving Cholesterol Metabolism and Atherosclerosis-Related Parameters in Subjects with Hypercholesterolemia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Nutrients 2023, 15, 661. [Google Scholar] [CrossRef] [PubMed]

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Reference

Article Metrics

Citations

Article Access Statistics